Cochlear Stock Forecast, Price & News

Cochlear (OTCMKTS:CHEOY) Frequently Asked Questions

Is Cochlear a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cochlear stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEOY, but not buy additional shares or sell existing shares.
View analyst ratings for Cochlear or view top-rated stocks.

What stocks does MarketBeat like better than Cochlear?

Wall Street analysts have given Cochlear a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cochlear wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cochlear?

Cochlear saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 100 shares, a decrease of 66.7% from the August 31st total of 300 shares. Based on an average daily volume of 2,000 shares, the days-to-cover ratio is currently 0.1 days.
View Cochlear's Short Interest.

How has Cochlear's stock been impacted by COVID-19 (Coronavirus)?

Cochlear's stock was trading at $60.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CHEOY stock has increased by 32.8% and is now trading at $80.02.
View which stocks have been most impacted by COVID-19.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a dividend on Thursday, September 16th. Investors of record on Thursday, September 23rd will be paid a dividend of $0.9535 per share on Tuesday, November 2nd. This represents a yield of 1.13%. The ex-dividend date of this dividend is Wednesday, September 22nd. This is a positive change from Cochlear's previous dividend of $0.45.
View Cochlear's dividend history.

Who are Cochlear's key executives?

Cochlear's management team includes the following people:

• Diggory William Howitt, President, CEO, Executive Director & MD
• Stuart Sayers, Chief Financial Officer & President-Services
• Jan Janssen, Chief Technology Officer
• David Hackshall, Chief Information Officer
• Matthew Prior, VP-Finance & Commercial Operations-Asia Pacific

Who are some of Cochlear's key competitors?

Some companies that are related to Cochlear include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOF).
View all of CHEOY's competitors.

What is Cochlear's stock symbol?

Cochlear trades on the OTCMKTS under the ticker symbol "CHEOY."

How do I buy shares of Cochlear?

Shares of CHEOY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cochlear's stock price today?

One share of CHEOY stock can currently be purchased for approximately $80.02.

How many employees does Cochlear have?

Cochlear employs 4,000 workers across the globe.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

Where are Cochlear's headquarters?

Cochlear is headquartered at 1 University Avenue, Sydney, New South Wales 2109.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue, Sydney, New South Wales 2109. The company can be reached via phone at (129) 428-6555.